Your session is about to expire
← Back to Search
Remdesivir for COVID-19 (CARAVAN Trial)
CARAVAN Trial Summary
This trial will study the safety and effectiveness of the drug remdesivir in kids aged 0-18 who have been diagnosed with COVID-19.
- COVID-19
- Coronavirus
CARAVAN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 1062 Patients • NCT04280705CARAVAN Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being welcomed into this experiment?
"To move forward with the study, a total of 62 patients that pass the clinical trial's inclusion criteria are needed. The sponsor, Gilead Sciences, will be managing the trial from different locations including Children's Hospital of Alabama in Birmingham and NYC Health + Hospitals/Jacobi Medical Center in Bronx."
Is this trial being conducted at a great number of locations within the state?
"Children's Hospital of Alabama in Birmingham, Alabama, NYC Health + Hospitals/Jacobi Medical Center in Bronx, New york, and Northwell Health-Cohen Children's Medical Center are all participating locations for this trial. An additional 17 hospitals are also included."
Has this experiment been conducted before?
"AbbVie first sponsored a study on Remdesivir in 2020. This initial Phase 3 drug approval trial had 2900 participants and was conducted in 183 cities across 36 countries. As of today, there are 10 active studies being performed to research the effects of Remdesivir."
Can you please tell me what other drug studies Remdesivir has been used in?
"Remdesivir was first studied at Island Health - Victoria General Hospital in 2020. As of now, there have been a total of 31 completed clinical trials. Out of the 10 active clinical trials, many are based in Birmingham, Alabama."
What has Remdesivir been commonly used to treat in the past?
"Remdesivir is often given to patients that fall in the weight range of 3.5 kilograms to less than 40 kilograms. Additionally, this medication can be used to treat other conditions such as a low spo2 level, supplemental oxygen requirements, and hospitalization."
Are recruitment efforts for this trial still underway?
"That is correct, the online information indicates that this study is still enrolling patients. The trial was initially posted on 7/21/2020 and has since been updated on 11/4/2022. Currently, 62 individuals are being sought from 17 different locations."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger